These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32607691)
21. CYBB/NOX2 in conventional DCs controls T cell encephalitogenicity during neuroinflammation. Keller CW; Kotur MB; Mundt S; Dokalis N; Ligeon LA; Shah AM; Prinz M; Becher B; Münz C; Lünemann JD Autophagy; 2021 May; 17(5):1244-1258. PubMed ID: 32401602 [TBL] [Abstract][Full Text] [Related]
22. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. Rostami A; Ciric B J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791 [TBL] [Abstract][Full Text] [Related]
24. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro. Wu H; Lo Y; Chan A; Law KS; Mok MY Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094 [TBL] [Abstract][Full Text] [Related]
25. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis. Yang C; He D; Yin C; Tan J Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284 [TBL] [Abstract][Full Text] [Related]
26. Effects of tolerogenic dendritic cells generated by siRNA-mediated RelB silencing on immune defense and surveillance functions of T cells. Luo L; Sun Z; Fang Q; Huang S; Bai X; Luo G Cell Immunol; 2013 Mar; 282(1):28-37. PubMed ID: 23665206 [TBL] [Abstract][Full Text] [Related]
27. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
28. Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathways. Shih VF; Davis-Turak J; Macal M; Huang JQ; Ponomarenko J; Kearns JD; Yu T; Fagerlund R; Asagiri M; Zuniga EI; Hoffmann A Nat Immunol; 2012 Dec; 13(12):1162-70. PubMed ID: 23086447 [TBL] [Abstract][Full Text] [Related]
29. Tolerogenic dendritic cells induced by BD750 ameliorate proinflammatory T cell responses and experimental autoimmune encephalitis in mice. Zhou Y; Leng X; Li H; Yang S; Yang T; Li L; Xiong Y; Zou Q; Liu Y; Wang Y Mol Med; 2017 Oct; 23():204-214. PubMed ID: 28960227 [TBL] [Abstract][Full Text] [Related]
30. Preventing immune rejection through gene silencing. Zhang X; Li M; Min WP Methods Mol Biol; 2010; 623():357-71. PubMed ID: 20217563 [TBL] [Abstract][Full Text] [Related]
31. [Effect of apigenin on dendritic cells maturation and function in murine splenocytes]. Liu YF; Xue XX; Li ZY; Wang JP; Zhang YJ Yao Xue Xue Bao; 2017 Mar; 52(3):397-402. PubMed ID: 29979844 [TBL] [Abstract][Full Text] [Related]
32. A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitis. Gupta AS; Biswas DD; Brown SN; Mockenhaupt K; Marone M; Hoskins A; Siebenlist U; Kordula T J Neuroinflammation; 2019 Jul; 16(1):161. PubMed ID: 31362762 [TBL] [Abstract][Full Text] [Related]
33. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis. Pennell LM; Fish EN Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573 [TBL] [Abstract][Full Text] [Related]
34. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE. Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice. Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy. Bertin-Maghit S; Pang D; O'Sullivan B; Best S; Duggan E; Paul S; Thomas H; Kay TW; Harrison LC; Steptoe R; Thomas R Diabetes; 2011 Jan; 60(1):248-57. PubMed ID: 20980463 [TBL] [Abstract][Full Text] [Related]
37. Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells. Geisel J; Brück J; Glocova I; Dengler K; Sinnberg T; Rothfuss O; Walter M; Schulze-Osthoff K; Röcken M; Ghoreschi K J Immunol; 2014 Apr; 192(8):3530-9. PubMed ID: 24639357 [TBL] [Abstract][Full Text] [Related]
38. Docosahexaenoic acid prevents dendritic cell maturation, inhibits antigen-specific Th1/Th17 differentiation and suppresses experimental autoimmune encephalomyelitis. Kong W; Yen JH; Ganea D Brain Behav Immun; 2011 Jul; 25(5):872-82. PubMed ID: 20854895 [TBL] [Abstract][Full Text] [Related]
39. Dendritic cells transduced with lentiviral-mediated RelB-specific ShRNAs inhibit the development of experimental autoimmune myasthenia gravis. Zhang Y; Yang H; Xiao B; Wu M; Zhou W; Li J; Li G; Christadoss P Mol Immunol; 2009 Feb; 46(4):657-67. PubMed ID: 19038457 [TBL] [Abstract][Full Text] [Related]
40. 1,25-dihydroxyvitamin D Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]